Report cover image

North America Travel Vaccines Market Report, 2025-2033

Publisher IMARC Services Pvt. Ltd.
Published Aug 01, 2025
Length 123 Pages
SKU # IMRC20290519

Description

The North America travel vaccines market size reached USD 2.01 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.24 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033.

Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc.

North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the North America travel vaccines market report, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on composition and disease.
  • Key Regions Analysed
United States

Canada

Mexico
  • Analysis for Each Country
  • Market by Composition
    • Mono Vaccines

    Combination Vaccines
  • Market by Disease
    • Hepatitis A

    DPT

    Yellow Fever

    Typhoid

    Hepatitis B

    Measles and Mumps

    Rabies

    Meningococcal

    Varicella

    Japanese Encephalitis

    Others
  • Value Chain Analysis
  • Key Drivers and Challenges
  • Porters Five Forces Analysis
  • PESTEL Analysis
  • Government Regulations
  • Competitive Landscape
    • Competitive Structure

    Key Player Profiles

    Key Questions Answered in This Report

    1.What was the size of the North America travel vaccines market in 2024?

    2.What is the expected growth rate of the North America travel vaccines market during 2025-2033?

    3.What are the key factors driving the North America travel vaccines market?

    4.What has been the impact of COVID-19 on the North America travel vaccines market?

    5.What is the breakup of the North America travel vaccines market based on the composition?

    6.What is the breakup of the North America travel vaccines market based on the disease?

    7.What are the key regions in the North America travel vaccines market?

    Table of Contents

    123 Pages
    1 Preface
    2 Scope and Methodology
    2.1 Objectives of the Study
    2.2 Stakeholders
    2.3 Data Sources
    2.3.1 Primary Sources
    2.3.2 Secondary Sources
    2.4 Market Estimation
    2.4.1 Bottom-Up Approach
    2.4.2 Top-Down Approach
    2.5 Forecasting Methodology
    3 Executive Summary
    4 Introduction
    4.1 Overview
    4.2 Key Industry Trends
    5 Global Travel Vaccines Market
    5.1 Market Performance
    5.2 Market Breakup by Composition
    5.3 Market Breakup by Disease
    5.4 Market Breakup by Region
    5.5 Market Forecast
    6 North America Travel Vaccines Market
    6.1 Market Performance
    6.2 Impact of COVID-19
    6.3 Market Forecast
    7 North America Travel Vaccines Market: Breakup by Composition
    7.1 Mono Vaccines
    7.2 Combination Vaccines
    8 North America Travel Vaccines Market: Breakup by Disease
    8.1 Hepatitis A
    8.2 DPT
    8.3 Yellow Fever
    8.4 Typhoid
    8.5 Hepatitis B
    8.6 Measles and Mumps
    8.7 Rabies
    8.8 Meningococcal
    8.9 Varicella
    8.10 Japanese Encephalitis
    8.11 Others
    9 North America Travel Vaccines Market: Breakup by Country
    9.1 United States
    9.1.1 Historical Market Trends
    9.1.2 Market Breakup by Composition
    9.1.3 Market Breakup by Disease
    9.1.4 Market Forecast
    9.2 Canada
    9.2.1 Historical Market Trends
    9.2.2 Market Breakup by Composition
    9.2.3 Market Breakup by Disease
    9.2.4 Market Forecast
    9.3 Mexico
    9.3.1 Historical Market Trends
    9.3.2 Market Breakup by Composition
    9.3.3 Market Breakup by Disease
    9.3.4 Market Forecast
    10 SWOT Analysis
    10.1 Overview
    10.2 Strengths
    10.3 Weaknesses
    10.4 Opportunities
    10.5 Threats
    11 Value Chain Analysis
    11.1 Overview
    11.2 Exploratory Stage
    11.3 Preclinical and Clinical Development
    11.4 Regulatory Approval
    11.5 Manufacturing
    11.6 Marketing and Distribution
    12 Porter’s Five Forces Analysis
    12.1 Overview
    12.2 Bargaining Power of Buyers
    12.3 Bargaining Power of Suppliers
    12.4 Degree of Rivalry
    12.5 Threat of New Entrants
    12.6 Threat of Substitutes
    13 Price Analysis
    14 Competitive Landscape
    14.1 Market Structure
    14.2 Key Players
    14.3 Profiles of Key Players

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us